Aquestive Therapeutics, Inc. - 8-K Filing

Aquestive Therapeutics amended its bylaws to remove requirements for stockholder nominations regarding relationships with 'others acting in concert' on October 15, 2026.

SEC EDGAR ·

Tickers: $AQST

Read the full article at SEC EDGAR

More Regulatory news